Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000779250 | SCV000915813 | uncertain significance | Deficiency of alpha-mannosidase | 2018-09-25 | criteria provided, single submitter | clinical testing | The MAN2B1 c.856G>A (p.Glu286Lys) variant is a missense variant that has been reported in a compound heterozygous state with a second missense variant in one individual alpha-mannosidosis (Wu et al. 2014). The p.Glu286Lys variant was absent from 100 control subjects but was reported at a frequency of 0.000012 in the Total population of the Genome Aggregation Database. The evidence for this variant is limited. The p.Glu286Lys variant is classified as unknown significance but suspicious for pathogenicity for alpha-mannosidosis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Ce |
RCV002510974 | SCV002822514 | likely pathogenic | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | MAN2B1: PM2, PM3, PP1, PP4 |
Baylor Genetics | RCV000779250 | SCV004191901 | likely pathogenic | Deficiency of alpha-mannosidase | 2024-02-14 | criteria provided, single submitter | clinical testing | |
Centre de Biologie Pathologie Génétique, |
RCV000779250 | SCV001428322 | likely pathogenic | Deficiency of alpha-mannosidase | 2019-01-01 | no assertion criteria provided | clinical testing |